IL10 and hepatocellular carcinoma: Overall, IL-10 (-1082 A/G) showed a tendency toward significant relationship with hepatocellular carcinoma under heterozygous model (OR: 0.82, 95%CI:0.67-1.0, I2 = 49%, fixed effect model, 9 studies), however other four genetic models did not (All p values > 0.05) (Table 2).